Occudo Quantitative Strategies’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,117
Closed -$297K 703
2024
Q3
$297K Buy
+22,117
New +$326K 0.05% 460
2023
Q2
Sell
-23,258
Closed -$519K 1041
2023
Q1
$519K Buy
23,258
+2,335
+11% +$61.2K 0.05% 510
2022
Q4
$556K Sell
20,923
-21,349
-51% -$697K 0.06% 471
2022
Q3
$1.2M Buy
42,272
+9,038
+27% +$232K 0.09% 334
2022
Q2
$692K Buy
33,234
+5,369
+19% +$101K 0.06% 505
2022
Q1
$604K Buy
27,865
+12,210
+78% +$265K 0.05% 574
2021
Q4
$435K Buy
+15,655
New +$380K 0.04% 658

Other funds holding CCRN

Occudo Quantitative Strategies's CCRN Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Cross Country Healthcare (CCRN) in Q4 2024, closing a stake of 22,117 shares — an estimated $297K sold.

Occudo Quantitative Strategies first reported a position in CCRN in Q4 2021 and held it in 7 quarters. The position peaked at $1.2M in Q3 2022. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Cross Country Healthcare position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 22,117 Cross Country Healthcare shares in Q4 2024, an estimated $297K.
  • Occudo Quantitative Strategies first reported a position in Cross Country Healthcare in Q4 2021 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Cross Country Healthcare position peaked at $1.2M in Q3 2022.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.